Bharat Biotech to manufacture 2 crore doses of Covaxin at UP`s Bulandshahr plant every month

As states face an acute shortage of COVID-19 vaccines, the central government on Wednesday (May 12, 2021) approved the proposal of Bharat Biotech to set up a new plant of Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) in Uttar Pradesh’s Bulandshahr.

https://ift.tt/eA8V8J from https://ift.tt/2SOB17Z